CG-2608

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug NameCG-2608

Drug Alias NameCG-2608

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionMatrix metalloproteinase-2 inhibitorsMatrix metalloproteinase 9 inhibitors

TargetsMatrix metalloproteinase 9Matrix metalloproteinase-2

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesCelltrion Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesCelltrion Inc

Active IndicationsN/A

Inactive IndicationsNeoplasms

ATC CodeN/A